Bill Summary for H 563 (2023-2024)
Printer-friendly: Click to view
Summary date:
- Agriculture
- Business and Commerce
- Occupational Licensing
- Courts/Judiciary
- Criminal Justice
- Criminal Law and Procedure
- Education
- Elementary and Secondary Education
- Government
- APA/Rule Making
- Budget/Appropriations
- State Agencies
- UNC System
- Department of Health and Human Services
- Department of Public Safety
- Department of Revenue
- Tax
- Health and Human Services
- Health
- Health Care Facilities and Providers
Bill Information:
| View NCGA Bill Details | 2023-2024 Session |
AN ACT TO REGULATE THE SALE AND DISTRIBUTION OF HEMP-DERIVED CONSUMABLE PRODUCTS, TO IMPOSE AN EXCISE TAX ON THOSE PRODUCTS, TO BAN THOSE PRODUCTS FROM SCHOOL GROUNDS, TO PLACE TIANEPTINE, XYLAZINE, AND KRATOM ON THE CONTROLLED SUBSTANCE SCHEDULES, TO CREATE THE OFFENSE OF CRIMINAL POSSESSION AND UNLAWFUL SALE OF EMBALMING FLUID AND TO MAKE OTHER TECHNICAL REVISIONS, TO CREATE NEW CRIMINAL OFFENSES FOR EXPOSING A CHILD TO A CONTROLLED SUBSTANCE TO ENACT THE NORTH CAROLINA COMPASSIONATE CARE ACT, AND TO REQUIRE CERTAIN EDUCATION ABOUT OPIOIDS.Intro. by McNeely, Sasser, Cotham, Fontenot.
| View: All Summaries for Bill | Tracking: |
Bill summary
Senate amendments make the following changes to the 7th edition.
Amendment #1 makes the following changes.
Part IX
Section 9
Increases the membership of the Medical Cannabis Production Commission (Commission) under GS 90-113.118 from eleven to thirteen members by adding a pharmacist appointed by the General Assembly upon recommendation of the Speaker of the House and a medical doctor with five years’ experience practicing in an emergency room appointed by the General Assembly upon recommendation of the President Pro Tempore of the Senate. Directs that the pharmacist appointee’s term will expire on June 30 of any year evenly divisible by four and the doctor appointee’s term will expire on June 30 of any year that follows by two years a year evenly divisible by four.
Amendment #3 makes the following changes.
Part I
Section 1
Amends the sales restriction on hemp-derived consumable products under GS 18D-101(a)(4) by changing the amount of concentration in the consumable product to .3% on a dry weight basis of delta-9 tetrahydrocannabinol (was, dry weight basis total combined). Amends the sales restriction on hemp-derived consumable products under GS 18D-101(a)(6) by adding those that are not contained in child-proof packing as a violation of statute.
Amends the offenses involving the manufacture and distribution of hemp-derived consumable products under GS 18D-103(a)(3) by changing the amount of concentration in the consumable product to .3% on a dry weight basis of delta-9 tetrahydrocannabinol (was, dry weight basis total combined).
Amends the testing requirement prior to distribution under GS 18D-104(b) so that cannabinoids cannot exceed a concentration of .3% on a dry weight basis of delta-9 tetrahydrocannabinol (was, .3% total combined).
Amends the additional packing requirements under GS 18D-105(a)(2) so that the list of ingredients/allergens and analysis information can be accessed via a QR code (was, code). Specifies that vaporization under the additional inhalable product restrictions under GS 18D-105(c2) includes the heating of hemp-derived oil to release aerosolized hemp-derived cannabinoids. Requires that a license issued under Article 1 of GS Chapter 18D be annually renewed (previously, gave discretion as to annual renewal) under GS 15D-105(d).
Part IV
Section 6
Changes the effective date of the act’s changes to GS 90-94 (schedule VI controlled substances) from December 1, 2024 to June 1, 2025. Specifies the provision applies to offenses committed on or after that date.